Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina

Human Vaccines

Volumn 7, Issue 10, 2011, Pages

  Fridman, Diego ^a   Monti, Andrea ^a   Bonnet, Marie Claude ^b   Armoni, Judith ^c   Stamboulian, Daniel ^a  

^a Centro de Estudios Infectologicos   (Argentina)

^b SANOFI PASTEUR   (France)

^c Sanofi Pasteur   (Argentina)

Author keywords

Safety; Schedule; Tolerability; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE;

ACUTE OTITIS MEDIA; ALLERGY; ARGENTINA; ARTICLE; BRONCHIOLITIS; CHICKENPOX; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DERMATITIS; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; FOOD ALLERGY; GASTROENTERITIS; HEMATOMA; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE RASH; INJECTION SITE SWELLING; INJECTION SITE WARMTH; LYMPHADENITIS; MALAISE; MALE; MYALGIA; NORMAL HUMAN; OTALGIA; OTITIS; PETECHIA; PHARYNGITIS; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; RASH; RHINITIS; RHINOPHARYNGITIS; SINGLE DRUG DOSE; SINUSITIS; SORE THROAT; TOOTH PAIN; TREATMENT OUTCOME; VACCINATION; VARICELLA ZOSTER VIRUS; VOMITING; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; FEVER; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; SKIN DISEASE;

ARGENTINA; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; EXANTHEMA; FEVER; HUMANS; IMMUNIZATION, SECONDARY; MALE; SKIN DISEASES; VACCINATION; VACCINES, ATTENUATED;

EID: 85046981058     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.10.17816     Document Type: Article

References (19)

1. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-40.
2. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med 2009; 7:26.
3. Gil A, Gil R, Alvaro A, San Martín M, González A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis 2009; 9:55.
4. Heininger U, Seward JF. Varicella. Lancet 2006; 368:1365-76. (Pubitemid 44540319)
5. Banz K, Iseli A, Aebi C, Brunner M, Schmutz AM, Heininger U. Economic evaluation of varicella vaccination in Swiss children and adolescents. Hum Vaccin 2009; 5:847-57.
6. Bonanni P, Boccalini S, Bechini A, Banz K. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases. Vaccine 2008; 26:5619-26.
7. Azzari C, Massai C, Poggiolesi C, Indolfi G, Spagnolo G, De Luca M, et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin 2007; 23:2945-54.
8. Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 1998; 73:241-8.
9. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med 2009; 7:26.
10. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996; 45:1-36.
11. Centers for Disease Control and Prevention. National, state and urban area vaccination coverage among children aged 19-35 months - United States 2004. MMWR Morb Mortal Wkly Rep 2005; 54:717-21.
12. Galil K, Pletcher MJ, Wallace BJ, Seward J, Meyer PA, Baughman AL, et al. Tracking varicella deaths: accuracy and completeness of death certificates and hospital discharge records, New York State 1989-95. Am J Public Health 2002; 92:1248-50. (Pubitemid 34815785)
13. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States 1995-2000. JAMA 2002; 287:606-11. (Pubitemid 34252012)
14. Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 2006; 117:1070-7.
15. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2006; 55:993-5.
16. Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-40.
17. Takahashi M. 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview. Paediatr Drugs 2001; 3:285-92. (Pubitemid 32391809)
18. Lau YL, Vessey SJ, Chan IS, et al. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine 2002; 20:2942-9. (Pubitemid 34785965)
19. Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis 1996; 174 Suppl 3:S310-S313. (Pubitemid 26357213)